| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 11043058 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 162 journal articles in the PubMed database | Email to a friend | | |
| Borgbjerg FM, Rosenberg J
[Oral transmucosal fentanyl citrate (OTFC) in the treatment of breakthrough pain] [Journal Article]
Ugeskr Laeger 2000 Sep 25; 162(39):5237-40.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Farrar JT, Cleary J, Rauck R, et al.
Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Natl Cancer Inst 1998 Apr 15; 90(8):611-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Mystakidou K, Katsouda E, Parpa E, et al.
Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics. [Journal Article]
J Opioid Manag 2005 Mar-Apr; 1(1):36-40.
Abstract | Full Citation | | Portenoy RK, Payne R, Coluzzi P, et al.
Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Pain 1999 Feb; 79(2-3):303-12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Mystakidou K, Katsouda E, Parpa E, et al.
Oral transmucosal fentanyl citrate: overview of pharmacological and clinical characteristics. [Journal Article]
Drug Deliv 2006 Jul-Aug; 13(4):269-76.
Abstract | Full Citation | Find Related Articles | | Blick SK, Wagstaff AJ
Fentanyl buccal tablet : in breakthrough pain in opioid-tolerant patients with cancer. [Journal Article]
Drugs 2006; 66(18):2387-93.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Christie JM, Simmonds M, Patt R, et al.
Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Clin Oncol 1998 Oct; 16(10):3238-45.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Payne R, Coluzzi P, Hart L, et al.
Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain. [Clinical Trial, Journal Article, Multicenter Study]
J Pain Symptom Manage 2001 Jul; 22(1):575-83.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Zeppetella G, Ribeiro MD
Opioids for the management of breakthrough (episodic) pain in cancer patients. [Journal Article, Meta-Analysis, Review]
Cochrane Database Syst Rev 2006; (1):CD004311.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
